Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$5,368,739
+$697,272 QoQ
Shares Held
21,335
-0.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#1,264
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIONS FINANCIAL GROUP INC, /IA/ /ADV holds $42,950,041 across 11 Drug Manufacturers - General names. ABBV ranks #4 (12.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,271 | $13,518,776 | |
| 2 | JNJ |
Johnson & Johnson
|
37,265 | $9,464,192 | |
| 3 | AMGN |
Amgen Inc
|
16,562 | $5,997,431 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
21,335 | $5,368,739 | |
| 5 | MRK |
Merck & Co., Inc.
|
23,911 | $3,072,563 | |
| 6 | PFE |
Pfizer Inc
|
71,165 | $1,713,653 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,741 | $1,137,476 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,753 | $853,174 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,368,739 | 21,335 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $4,671,467 | 21,479 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $4,884,202 | 21,376 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $3,801,886 | 16,420 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $3,045,281 | 16,406 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,409,309 | 16,272 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,488,333 | 14,003 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $5,521,145 | 27,958 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $4,012,195 | 23,392 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $2,631,345 | 14,450 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $2,453,175 | 15,830 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,383,022 | 15,987 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,181,682 | 16,193 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,652,235 | 16,642 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,706,805 | 16,749 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,033,549 | 15,152 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,223,540 | 27,576 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,496,015 | 33,903 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,422,028 | 32,659 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,471,131 | 13,638 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,105,336 | 9,813 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,052,655 | 9,727 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,386,628 | 12,941 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,032,948 | 11,793 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,105,899 | 11,264 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $770,661 | 10,115 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||